TENZIN DEKYI: Open Payments
NPI 1295482875 · EAST ELMHURST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 20 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $955
Food & beverage: $665Education: $290
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 4 | $208 |
| Merck Sharp & Dohme LLC | 5 | $205 |
| Janssen Biotech, Inc. | 3 | $152 |
| AstraZeneca Pharmaceuticals LP | 2 | $120 |
| SEAGEN INC. | 1 | $100 |
| ACCORD HEALTHCARE, INC. | 1 | $67 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $30 |
| Blue Earth Diagnostics | 1 | $25 |
| PFIZER INC. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $22 |
Products named: Lenvima, KEYTRUDA, ERLEADA, LYNPARZA, Camcevi, PYLARIFY, POSLUMA, PADCEV.
Industry payments across NY — which companies pay providers there.
